共 35 条
[1]
Bebchuk LA(1984)Litigation and settlement under imperfect information The RAND Journal of Economics 15 404-415
[2]
Bulow J(2004)The gaming of pharmaceutical patents Innovation Policy and the Economy 4 145-187
[3]
Carrier MA(2010)A real-world analysis of pharmaceutical settlements: The missing dimension of product hopping Florida Law Review 62 1009-424
[4]
Carrier MA(2011)Provigil: A case study of anticompetitive behavior Hastings Science & Technology Law Journal 3 441-158
[5]
Che YK(1993)The role of precedents in repeated litigation Journal of Law, Economics, & Organization 9 399-901
[6]
Yi JG(2009)An economic assessment of patent settlements in the pharmaceutical industry Annals of Health Law 19 367-119
[7]
Dickey B(2015)The Actavis inference: Theory and practice Rutgers University Law Review 67 585-38
[8]
Orszag J(2016)Drug wars: A new generation of generic pharmaceutical delay Harvard Journal on Legislation 53 499-98
[9]
Tyson L(2016)A new dimension to EU pharma antitrust product hopping and unilateral pay for delay European Competition Journal 12 137-55
[10]
Edlin A(2017)A framework for estimating damages in reverse payment cases Antitrust Law Journal 81 873-undefined